<html>
<head>PUBMED IDs for ILF3</head>
<body bgcolor='#C5F0F2'><h1>ILF3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9620363/'>Mapping interleukin enhancer binding factor 3 gene (ILF3) to human chromosome 19 (19q11-qter and 19p11-p13.1) by polymerase chain reaction amplification of human-rodent somatic cell hybrid DNA templates.</a> June 10  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10337617/'>Cloning and characterization of the mouse interleukin enhancer binding factor 3 (Ilf3) homolog in a screen for RNA binding proteins.</a> May 25  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10749851/'>Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3.</a> April 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11167023/'>Alternative splicing in the human interleukin enhancer binding factor 3 (ILF3) gene.</a> February 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11777942/'>Exportin-5, a novel karyopherin, mediates nuclear export of double-stranded RNA binding proteins.</a> January 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14654356/'>Cell cycle dependent intracellular distribution of two spliced isoforms of TCP/ILF3 proteins.</a> December 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15254228/'>Nucleocytoplasmic shuttling of JAZ, a new cargo protein for exportin-5.</a> July 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15817156/'>NF45/ILF2 tissue expression, promoter analysis, and interleukin-2 transactivating function.</a> April 9  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16428770/'>Identification of proteins differentially expressed in human monocytes exposed to Porphyromonas gingivalis and its purified components by high-throughput immunoblotting.</a> January 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16533607/'>Molecular cloning, characterization and expression analysis of grass carp (Ctenopharyngodon idellus) NF45 (ILF2) cDNA, a subunit of the nuclear factor of activated T-cells (NF-AT).</a> March 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17765891/'>Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins.</a> September 4  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/23136613/'>Gene expression patterns in the histopathological classification of epithelial ovarian cancer.</a> January 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23136613/'>Gene expression patterns in the histopathological classification of epithelial ovarian cancer.</a> January 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20935053/'>The evolution and expression of the snaR family of small non-coding RNAs.</a> May 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21468600/'>Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with different lipid profiles.</a> July 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21554248/'>Interleukin enhancer-binding factor 3 functions as a liver receptor homologue-1 co-activator in synergy with the nuclear receptor co-activators PRMT1 and PGC-1Î±.</a> September 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21971700/'>Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.</a> February 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22014684/'>Proteomic profiling of the human T-cell nucleolus.</a> January 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22382325/'>Interactions of thyroid hormone receptor with Ku proteins and interleukin enhancer binding factor 3 modulate the promoter activity of thyroid-stimulating hormone alpha.</a> June 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22382316/'>Influence of cytochrome P450 2C19 gene variations on pharmacokinetic parameters of thalidomide in Japanese patients.</a> June 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22442257/'>Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin.</a> October 31  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22842455/'>Sepantronium bromide (YM155) induces disruption of the ILF3/p54(nrb) complex, which is required for survivin expression.</a> January 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22986534/'>Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression.</a> December 16  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23321469/'>Proteomic analysis of interleukin enhancer binding factor 3 (Ilf3) and nuclear factor 90 (NF90) interactome.</a> November 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23321468/'>An updated meta-analysis of XRCC4 polymorphisms and cancer risk based on 31 case-control studies.</a> July 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24430196/'>The effect of Rho-associated kinase inhibition on the proteome pattern of dissociated human embryonic stem cells.</a> October 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25544776/'>The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway.</a> January 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26398198/'>SERBP1 Is a Component of the Liver Receptor Homologue-1 Transcriptional Complex.</a> September 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26647875/'>The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.</a> September 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27840950/'>IMP-3 protects the mRNAs of cyclins D1 and D3 from GW182/AGO2-dependent translational repression.</a> November 15  2016<br></body></html>
